Vanguard Group
CALC icon

Vanguard Group’s CalciMedica CALC Stock Holding History

Vanguard Group’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$2.69M Buy
407,801
+31,177
+8% +$122K ﹤0.01% 3469
2025
Q3 		$1.14M Buy
376,624
+37,476
+11% +$108K ﹤0.01% 3752
2025
Q2 		$519K Hold
339,148
– – ﹤0.01% 3909
2025
Q1 		$648K Hold
339,148
– – ﹤0.01% 3823
2024
Q4 		$1.2M Buy
339,148
+85,000
+33% +$298K ﹤0.01% 3704
2024
Q3 		$1.13M Buy
254,148
+1,347
+0.5% +$5.92K ﹤0.01% 3733
2024
Q2 		$1M Buy
252,801
+239,442
+1,792% +$1.21M ﹤0.01% 3789
2024
Q1 		$55.6K Buy
+13,359
New +$61K ﹤0.01% 4307
2023
Q1 		– Sell
-29,995
Closed -$210K – 4558
2022
Q4 		$210K Buy
29,995
+13
+0% +$146 ﹤0.01% 4302
2022
Q3 		$394K Sell
29,982
-2,424
-7% -$34.3K ﹤0.01% 4278
2022
Q2 		$494K Sell
32,406
-135
-0.4% -$1.84K ﹤0.01% 4298
2022
Q1 		$561K Buy
32,541
+1,703
+6% +$32.4K ﹤0.01% 4376
2021
Q4 		$790K Sell
30,838
-76
-0.2% -$2.95K ﹤0.01% 4330
2021
Q3 		$1.44M Buy
30,914
+172
+0.6% +$9.67K ﹤0.01% 4157
2021
Q2 		$2.34M Buy
30,742
+13,683
+80% +$898K ﹤0.01% 3929
2021
Q1 		$1.32M Buy
17,059
+3,497
+26% +$1.05M ﹤0.01% 3948
2020
Q4 		$5.51M Buy
13,562
+6,419
+90% +$1.89M ﹤0.01% 3319
2020
Q3 		$1.27M Buy
+7,143
New +$1.49M ﹤0.01% 3600

Other funds holding CALC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
MPM
Meritage Portfolio Management Overland Park, Kansas $1.51B AUM 26.61% 1-Year Est. Return
SFFS
Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

Vanguard Group's CALC Position: Q4 2025 in Review

Vanguard Group increased its CalciMedica (CALC) stake by 8.3% in Q4 2025, buying an estimated $122K and bringing the position to 407,801 shares worth $2.69M. The position accounts for ﹤0.01% of the portfolio, ranked #3469.

Vanguard Group first reported a position in CALC in Q3 2020 and has held it in 18 quarters since. The position peaked at $5.51M in Q4 2020. 30 funds tracked by Wall St. Rank hold CALC as of Q4 2025.

  • Vanguard Group held 407,801 shares of CalciMedica worth $2.69M as of Q4 2025.
  • Vanguard Group bought 31,177 CalciMedica shares in Q4 2025, an estimated $122K.
  • CalciMedica made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3469 holding.
  • Vanguard Group first reported a position in CalciMedica in Q3 2020 and has held it in 18 quarters since.
  • Vanguard Group's CalciMedica position peaked at $5.51M in Q4 2020.
  • 30 funds tracked by Wall St. Rank held CalciMedica as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.